Asia Pacific Metabolic Testing Market By Product (CPET, Body Composition Analysis, ECG, Portable System), By Application (Critical Care, Lifestyle Diseases), By Technology (REE, Body Composition Analysis), By End User (Gym, Sports, Hospital) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)
According to the Asia Pacific Metabolic Testing Market Forecast Report, the market worth USD 69million in 2016 and estimated to grow at a CAGR of 7.2%, to reach USD 98million by 2021. The Asia Pacific Metabolic Testing market is developing at an exceptionally quick pace.
Browse Market data tables and in-depth TOC of the Asia Pacific Metabolic Testing Market to 2021 at www.marketdataforecast.com/market-…ting-market-4381/
Metabolism is a chemical reaction and physical process that involves maintenance of the living state, such as breathing, blood circulation, contraction of muscles, digestion of food and nutrients, elimination of wastes such as urine, controlling body temperature, and functioning of brain and nerves of the organism. It is a pathway that begins with a sequence of chemical reactions with a specific molecule and ends with a product with the help of specific enzyme.
Enzymes are vital to metabolism as they allow the organism to drive reactions for required energy. It is divided into two categories, i.e.
catabolism and anabolism. A comprehensive metabolic panel is a blood test that measures your sugar (glucose) level, electrolyte and fluid balance, kidney function, and liver function.
The significant driver is rising prevalence of lifestyle based diseases coupled with increasing geriatric population with high susceptibility towards developing chronic diseases such as cancer and kidney disorders. surge in technological advancements such as the introduction of digital metabolic rate testing equipment and rapidly increasing healthcare expenditure levels in developed and developing nations is boosting the industry.
The Asia Pacific Metabolic Testing Market Segmentation, on the basis of product, application, technology, End user and region. Based on product, the market is segmented into CPET, Body Composition Analysis, ECG, Software and Portable System.
Based on application, the market is segmented into critical care, dysmetabolic syndrome X, human performance testing, lifestyle diseases and other metabolic disorders. Based on technology the market is segmented into RMR analysis, VO2 max analysis and body composition analysis.
The VO2 max analysis segment attributes the largest share of the market. It directly measures the body oxygen consumption, which other tests try to estimate.
Based on End user, the market is segmented into laboratories, hospitals, gyms and sports training centers.
Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia and South East Asia. China and India are likely to increase the market because of huge population.
Asia Pacific is largest growing segment.
Metabolic Testing Market Leaders are, Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc.
(U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...